Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › P1-(2′-deoxycytidine 5′-)P4-(uridine 5′-)tetraphosphate, tetra-(alkali metal) salt, for treating cystic fibrosis

P1-(2′-deoxycytidine 5′-)P4-(uridine 5′-)tetraphosphate, tetra-(alkali metal) salt, for treating cystic fibrosis

US Patent 7531525 · Granted May 12, 2009

Estimated economic value: $4,223,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compounds, compositions, and methods for selectively inhibiting β-glucuronidases2024
Method of treating Parkinson's Disease with a diarylmethylpiperazine compounds e2018
Method of treating Parkinson's disease with a diarylmethylpiperazine compounds e2017
Delta opioid receptor agonist compounds2016
Delta opioid receptor agonist compounds2014
Method of treating Parkinson's Disease with diarylmethylpiperazine compounds exh2014
Cytoskeletal active rho kinase inhibitor compounds, composition and use2013
Cytoskeletal active rho kinase inhibitor compounds, composition and use2013
Method of treating sexual dysfunctions with delta opioid receptor agonist compou2013
Delta opioid receptor agonist compounds2013
Compositions and methods for combating lower urinary tract dysfunctions with del2013
Method for treating diseases associated with alterations in cellular integrity u2013